Paul Gillard

Paul Gillard

UNVERIFIED PROFILE

Are you Paul Gillard?   Register this Author

Register author
Paul Gillard

Paul Gillard

Publications by authors named "Paul Gillard"

Are you Paul Gillard?   Register this Author

36Publications

662Reads

8Profile Views

Phase 2b Controlled Trial of M72/AS01 Vaccine to Prevent Tuberculosis.

N Engl J Med 2018 10 25;379(17):1621-1634. Epub 2018 Sep 25.

From GlaxoSmithKline, Wavre, Belgium (O.V.D.M., M.-A.D., T.S., E.J.A., A.K.A., A.B., P.G.); South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology (M.H., T.J.S., M.T.), and Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine (R.J.W., F.T.), University of Cape Town, Task Applied Science (E.V.B., A.D.), Stellenbosch University (A.D.), and Aeras Global TB Vaccine Foundation (D.R.T.) Cape Town, Setshaba Research Centre, Pretoria (M. Malahleha), the Aurum Institute, Klerksdorp and Tembisa Research Centres (J.C.I.), and the Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, South African Medical Research Council Collaborating Centre for HIV/AIDS and TB, and National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, University of the Witwatersrand (N.M.), Johannesburg, and Be Part Yoluntu Centre, Paarl (E.H.) - all in South Africa; Kenya Medical Research Institute, Nairobi (V.N.); Francis Crick Institute (R.J.W.), the Department of Medicine, Imperial College London (R.J.W.), and the London School of Hygiene and Tropical Medicine (H.M.A.) - all in London; Centre for Infectious Disease Research in Zambia (M. Muyoyeta, G.H.) and Zambart, University of Zambia (H.M.A.) - both in Lusaka, Zambia; the Department of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland (F.T.); and Aeras, Rockville (G.L.B., A.M.G., T.G.E.), and Johns Hopkins University Center for Tuberculosis Research, Baltimore (N.M.) - both in Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1803484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151253PMC
October 2018

Seeking help: B cells adapting to flu variability.

Sci Transl Med 2014 Jul;6(246):246ps8

GlaxoSmithKline Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3008409DOI Listing
July 2014

Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.

Hum Vaccin Immunother 2013 Jul 9;9(7):1512-22. Epub 2013 Apr 9.

Vaccine and Infectious Disease Institute; Centre for the Evaluation of Vaccination; University of Antwerp; Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.24504DOI Listing
July 2013

Safety and immunogenicity of a split-virion AS03A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults.

J Formos Med Assoc 2012 Jun 20;111(6):333-9. Epub 2012 Apr 20.

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfma.2011.02.006DOI Listing
June 2012

Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.

Vaccine 2011 Nov 18;29(51):9508-13. Epub 2011 Oct 18.

Hospital Maternidad Nuestra Sra de la Altagracia, Santo Domingo, Dominican Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2011.10.015DOI Listing
November 2011

Cross-clade immunogenicity and antigen-sparing with an AS03(A)-adjuvanted prepandemic influenza vaccine in a Thai population.

J Med Assoc Thai 2011 Aug;94(8):916-26

Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

View Article

Download full-text PDF

Source
August 2011

Effect of human rotavirus vaccine on severe diarrhea in African infants.

N Engl J Med 2010 Jan;362(4):289-98

Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
http://www.dspace.up.ac.za/bitstream/handle/2263/16825/Madhi
Web Search
http://www.nejm.org/doi/abs/10.1056/NEJMoa0904797
Publisher Site
http://dx.doi.org/10.1056/NEJMoa0904797DOI Listing
January 2010

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

Vaccine 2009 Oct;27(45):6284-90

Stiftung Juliusspital, Körperschaft des öffentlichen Rechts, Juliuspromenade 19, 97070 Würzburg, Germany.

View Article

Download full-text PDF

Source
October 2009